CUE vs MS · rev $9.3M vs P/E 20, $344.27B cap
Cue Biopharma (CUE) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
MS does not have a complete income-statement cache yet.
CUE currently screens at market cap $59.5M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CUE and MS stock pages for the full models.
Not investment advice.